Prader-Willi Syndrome Association | USA’s Post

Join PWSA | USA and the team from Acadia Pharmaceuticals on Tuesday, July 23 at 8:00 p.m. EST / 5:00 p.m. PST to learn more about the COMPASS PWS Study, which aims to investigate the drug Carbetocin (nasal spray) as a treatment for PWS, specifically to help address hyperphagia symptoms. Acadia representatives will give details about the drug and discuss their Phase 3 study openings, requirements, and more! They will also be available for a Q & A discussion for any questions you have. We invite you to sign up for this free webinar opportunity you won’t want to miss! Register TODAY at https://lnkd.in/gn39PVun.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics